BackTable Tumor Board

A multidisciplinary podcast for healthcare professionals who provide cancer care!

[BackTable Tumor Board @_backtableONC]

How do you manage recurrent low-grade upper tract urothelial carcinoma (UTUC) in an older patient?

This week’s Case Highlight features Drs. Nirmish Singla (@nirmishsingla), Jeannie Hoffman-Censits (@JCensits), and Bogdana Schmidt (@BogdanaSchmidt) discussing treatment considerations for recurrent low-grade UTUC in a 66-year-old patient, including endoscopic management and evolving treatment options.

Explore this case and more clinical discussions in the BackTable App: https://t.co/LLCOU2cqAG

#UTUC #UrologicOncology #Urology #BladderCancer @hopkinskimmel

[BackTable Tumor Board @_backtableONC]

What are you most looking forward to at #ESMO26 ?

[BackTable Tumor Board @_backtableONC]

“If you can get a #multidisciplinary team together, even if it's not the same room, do. [...] We're all learning together when the right timing is, who the right candidates are, and always consider trials.”
- @barbaraobrienmd on CNS Disease in #BreastCancer #ONC81 #ThinkPink #BreastCancerAwareness

[Flavio G Rocha, MD, FACS, FSSO @FlavioRochaMD]

Thank you 🙏 @TODAYshow for telling the ❤️
story of our amazing and courageous friend
and colleague @rachnatshroff @UAZCancer

We miss her and will continue to add to her
legacy @asco @curecc of fighting GI cancer

https://t.co/HtOU4c4U10

[BackTable Tumor Board @_backtableONC]

Always a pleasure!! 🙌🏼

[Ronan Hsieh, MD, MS @ronanhsieh]

Really excited to share a podcast I recorded with @Kate_Baker_MD @geoffreybuckle for HER2-amplified gastroesophageal cancer!

What makes it even more exciting is that a great new therapy mentioned in this podcast, tislelizumab + zanidatamab + chemotherapy, has now been approved by FDA as a first-line therapy. Given zanidatmab was shown to be superior to trastuzumab in this study, I'd use this new regimen for almost all 1L HER2-amplified advanced GEA.

Thanks @_backtableONC @AaronFrittsMD @jgong15 for invitation. It was a fun weekend at San Diego!

@DaniCastilloMD @Ahn_Daniel_Onc @IbrahimSahinMD1
#HERIZON

[Jun Gong, MD @jgong15]

#1L therapies in #HER2-positive advanced #GEJ #gastric cancer is a rapidly evolving space. Great insight from @geoffreybuckle @ronanhsieh @Kate_Baker_MD on this latest @_backtableONC episode

@AaronFrittsMD @DaniCastilloMD @_backtable @_backtableIND @BTWomensHealth @_backtableENT

[Nicholas Hornstein @GIMedOnc]

These algorithms are incredibly helpful for unpacking best practices buried in manuscripts and institutional knowledge.

[BackTable Tumor Board @_backtableONC]

HER2-positive gastroesophageal cancer has more first-line options than ever and very few head-to-head answers. 🧬

Dr. Geoffrey Buckle (@geoffreybuckle) and Dr. Ronan Hsieh (@ronanhsieh) join Dr. Kate Baker (@Kate_Baker_MD) on first-line choice, oligoprogression, HERIZON-GEA-01, rebiopsy and lung toxicity on trastuzumab deruxtecan.

Watch the full episode on the BackTable App: https://t.co/OCjDUEJXY5

#ONC86 #GastricCancer #EsophagealCancer #HER2 #GIOncology @TNOncology @UCSFCancer @ProvSwedish @theNCI

[Jun Gong, MD @jgong15]

To add, one of my former @CedarsSinai post-docs, Dr. Muranaka, brilliantly reviewed in @Cancers_MDPI how Gln supplementation could be a viable alternative to the convention of Gln deprivation as an #anticancer strategy #metabolicintervention

https://t.co/9T1b8UnbTr

@OncoAlert

[Jun Gong, MD @jgong15]

Thanks @montypal @DrJZell @christine_lovly @MOASC_Office for this great initiative & taking on one of our own @CedarsSinai #PTSP heme/onc fellows Dr. David Shia - the future is bright under this stellar mentorship panel! @kor_shah @AnthonyNguyenMD @Adam_Weiner535 @DaniCastilloMD

[BackTable Tumor Board @_backtableONC]

How do you approach head and neck squamous cell carcinoma with extensive nodal disease but a low-volume primary tumor?

This week’s Case Highlight features Drs. Dylan Roden, Ravindra Uppaluri (@DrUppaluri), and Adam Luginbuhl discussing treatment considerations for T2N3 head and neck squamous cell carcinoma, including the role of immunotherapy and surgical management.

Explore this case and more clinical discussions in the BackTable App: https://t.co/1bUqhBmUF5

#HeadAndNeckCancer #ENT #Oncology #Immunotherapy @_backtableENT @Kate_Baker_MD

[BackTable Tumor Board @_backtableONC]

@DaniCastilloMD @Kate_Baker_MD @StoCANcer We love having you! Thank you sharing your expertise 🙌🏼

[BackTable Tumor Board @_backtableONC]

The hardest decision in localized upper GI cancer is not how to operate. It is what happens in the four months before the operation.

Dr. Kate Baker (@Kate_Baker_MD) asks Dr. Dani Castillo (@DaniCastilloMD) and Dr. Alexandra Gangi (@AGangiMD) what they each need before a plan exists in esophageal, GEJ and gastric cancer, and where they still disagree. 📷

Watch the full episode on the BackTable App: https://t.co/Hhkrsx7618

#ONC85 #UpperGICancer #GastricCancer #EsophagealCancer #SurgicalOncology #MedOnc @cityofhope @CedarsSinai @TNOncology

[BackTable Tumor Board @_backtableONC]

#Myth or #Fact… "Survival for metastatic breast cancer has improved over recent decades."

#MetastaticBreastCancer #BreastCancerAwareness #ThinkPink #BackTable

[BackTable Vascular and Interventional @_backtable]

How does prior radiation turn a neck biopsy into a technical puzzle?

Dr. Majid Khan (@MajidKhan_spine) and Dr. Junjian Huang (@junjian_huang) join Dr. Neil Jain (@DigitalAngio) to share their approach for navigating trismus, carotid proximity, and drilling through sclerotic bone when standard techniques fall short.

Access the full episode in the BackTable app:
https://t.co/SnrBf4Ie0k

This podcast is supported by Varian OmniBone.

#VI672 #MSK112 #BoneBiopsy #PoweredAccess #SpineBiopsy #HeadAndNeck @NJIRSociety @JohnsHopkinsIR @EmoryIRad

[BackTable Tumor Board @_backtableONC]

How do you approach multifocal HCC in a patient without underlying cirrhosis?

This week’s Case Highlight features Drs. Gabriel Schnickel, Adam Burgoyne, Heather Patton (@Pattonhm1), Siddharth Padia (@SidpadiaIR), and Zach Berman (@ZTBerman) discussing treatment considerations for multifocal hepatocellular carcinoma in a non-cirrhotic patient.

Explore this case and more clinical discussions in the BackTable App: https://t.co/ICAmqcb6SF

#HCC #LiverCancer #InterventionalOncology #HepatobiliarySurgery @UCSDsurgery @RadiologyUcla @ucsd_IR

[Dr. Cathy Eng @CathyEngMD]

I’m grateful @theNCI R50 grant allows me to continue to attend #NCTN @SWOG group meetings. It also grants me the opportunity to interact w/ junior faculty members such as @ronanhsieh @DaniCastilloMD #EmersonChen #IIT #cancer #cancerresearch concepts! @HKennecke @VanMorrisMD @lisakachnic1 @NCIDirector

[BackTable Urology @_backtableUro]

Shifting from a default biopsy approach to a reflex test and MRI-first strategy could dramatically lower unnecessary procedures.

Dr. Tarik Benidir (@TarikBenidir) and Dr. Ruchika Talwar (@RuchikaTalwarMD) explain how this new workflow streamlines care and improves outcomes for both clinicians and patients.

Access the full episode in the BackTable app: https://t.co/NydNrJdAdy

This podcast is supported by Cleveland Diagnostics.

#URO325 #ProstateCancer #PSA #ProstateBiopsy #UrologicOncology @UF_Urology @VUMChealth

[Dani Castillo @DaniCastilloMD]

So great to see friends and mentors at #SWOG! Thankful for the guidance, inspiration, and friendships that make this community so special. #Oncology #CancerResearch @ronanhsieh @jgong15 @CathyEngMD @montypal @_backtableONC

[Jun Gong, MD @jgong15]

Won’t be quitting our day jobs 😎but what an experience walking #TheBlueJacketFashionShow LA for a great cause supporting #prostatecancer awareness👏🙌

With coverage by
@LAmag

https://t.co/du0TOSuxL5

@_TheKnockturnal

https://t.co/Jl84zWp3CS

@ABC7

https://t.co/nn7uwGU1a7